These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
777 related items for PubMed ID: 9417523
1. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med; 1997 Dec 25; 337(26):1861-9. PubMed ID: 9417523 [Abstract] [Full Text] [Related]
3. The perils of platelet transfusions. Kruskall MS. N Engl J Med; 1997 Dec 25; 337(26):1914-5. PubMed ID: 9407160 [No Abstract] [Full Text] [Related]
4. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy. Blundell EL, Pamphilon DH, Fraser ID, Menitove JE, Greenwalt TJ, Snyder EL, Repucci AJ, Hedberg SL, Anderson JK, Buchholz DH, Kagen LR, Aster RH. Transfusion; 1996 Apr 25; 36(4):296-302. PubMed ID: 8623127 [Abstract] [Full Text] [Related]
5. UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients. Grijzenhout MA, Aarts-Riemens MI, de Gruijl FR, van Weelden H, van Prooijen HC. Blood; 1994 Nov 15; 84(10):3524-31. PubMed ID: 7949107 [Abstract] [Full Text] [Related]
6. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group. Kao KJ, Mickel M, Braine HG, Davis K, Enright H, Gernsheimer T, Gillespie MJ, Kickler TS, Lee EJ, McCullough JJ. Transfusion; 1995 Jan 15; 35(1):13-9. PubMed ID: 7998062 [Abstract] [Full Text] [Related]
7. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study. Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A. Blood; 1995 Feb 01; 85(3):824-8. PubMed ID: 7833483 [Abstract] [Full Text] [Related]
8. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. van Marwijk Kooy M, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JW. Blood; 1991 Jan 01; 77(1):201-5. PubMed ID: 1984797 [Abstract] [Full Text] [Related]
10. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter]. Handa M, Ikeda Y, Kurata Y, Tsubaki K, Horiuchi A, Furihata K, Kimura Y, Toyama K, Takamoto S, Tsukimoto I. Rinsho Ketsueki; 1992 Apr 01; 33(4):451-60. PubMed ID: 1602608 [Abstract] [Full Text] [Related]
11. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D. Rev Med Chil; 1997 Nov 01; 125(11):1305-12. PubMed ID: 9609051 [Abstract] [Full Text] [Related]
12. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A, Picard C. Transfus Clin Biol; 2014 Nov 01; 21(4-5):193-206. PubMed ID: 25277423 [Abstract] [Full Text] [Related]
13. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness. Mishima Y, Tsuno NH, Matsuhashi M, Yoshizato T, Sato T, Ikeda T, Watanabe-Okochi N, Nagura Y, Sone S, Kurokawa M, Okazaki H. Transfus Apher Sci; 2015 Feb 01; 52(1):112-21. PubMed ID: 25467707 [Abstract] [Full Text] [Related]
14. [Refractory effect and alloimmunization after transfusion of thrombocytes]. Volkova RI, Agranenko VA. Gematol Transfuziol; 1992 Feb 01; 37(2):16-21. PubMed ID: 1426903 [Abstract] [Full Text] [Related]
15. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates. Ambruso DR, Thurman G, Marschner S, Goodrich RP. Transfusion; 2009 Dec 01; 49(12):2631-6. PubMed ID: 19694996 [Abstract] [Full Text] [Related]
16. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR. Blood; 1988 May 01; 71(5):1402-7. PubMed ID: 3282572 [Abstract] [Full Text] [Related]
17. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G. N Engl J Med; 1997 Dec 25; 337(26):1870-5. PubMed ID: 9407153 [Abstract] [Full Text] [Related]
18. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients. Hogge DE, McConnell M, Jacobson C, Sutherland HJ, Benny WB, Massing BG. Transfusion; 1995 Aug 25; 35(8):645-52. PubMed ID: 7631404 [Abstract] [Full Text] [Related]
19. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A. Blood; 1995 Apr 01; 85(7):1736-41. PubMed ID: 7703481 [Abstract] [Full Text] [Related]
20. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S. Transfus Med; 2018 Feb 01; 28(1):40-46. PubMed ID: 28516675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]